Guided Therapeutics GTHP Stock
Guided Therapeutics Price Chart
Guided Therapeutics GTHP Financial and Trading Overview
| Guided Therapeutics stock price | 0.09 USD |
| Previous Close | 0.18 USD |
| Open | 0.16 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.16 - 0.16 USD |
| 52 Week Range | 0.06 - 0.6 USD |
| Volume | 11.01K USD |
| Avg. Volume | 30.54K USD |
| Market Cap | 8.16M USD |
| Beta (5Y Monthly) | 0.644718 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GTHP Valuation Measures
| Enterprise Value | 12.42M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 272.05652 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 413.98 |
| Enterprise Value/EBITDA | -3.332 |
Trading Information
Guided Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.644718 |
| 52-Week Change | -64.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.6 USD |
| 52 Week Low | 0.06 USD |
| 50-Day Moving Average | 0.2 USD |
| 200-Day Moving Average | 0.31 USD |
GTHP Share Statistics
| Avg. Volume (3 month) | 30.54K USD |
| Avg. Daily Volume (10-Days) | 79.48K USD |
| Shares Outstanding | 51.01M |
| Float | 22.79M |
| Short Ratio | N/A |
| % Held by Insiders | 41.15% |
| % Held by Institutions | 12.17% |
| Shares Short | 0 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:800 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -12443.33% |
| Gross Margin | -196.66% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -91.87% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 30K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 340.00% |
| Gross Profit (ttm) | -68000 USD |
| EBITDA | -3727250 USD |
| Net Income Avi to Common (ttm) | -4886000 USD |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.84M USD |
| Total Cash Per Share (mrq) | 0.04 USD |
| Total Debt (mrq) | 2.11M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.637 |
| Book Value Per Share (mrq) | -0.116 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1798000 USD |
| Levered Free Cash Flow (ttm) | -1011000 USD |
Profile of Guided Therapeutics
| Country | United States |
| State | GA |
| City | Norcross |
| Address | 5835 Peachtree Corners East |
| ZIP | 30092 |
| Phone | (678) 329-7933 |
| Website | https://www.guidedinc.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Q&A For Guided Therapeutics Stock
What is a current GTHP stock price?
Guided Therapeutics GTHP stock price today per share is 0.09 USD.
How to purchase Guided Therapeutics stock?
You can buy GTHP shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Guided Therapeutics?
The stock symbol or ticker of Guided Therapeutics is GTHP.
Which industry does the Guided Therapeutics company belong to?
The Guided Therapeutics industry is Medical Devices.
How many shares does Guided Therapeutics have in circulation?
The max supply of Guided Therapeutics shares is 55.61M.
What is Guided Therapeutics Price to Earnings Ratio (PE Ratio)?
Guided Therapeutics PE Ratio is now.
What was Guided Therapeutics earnings per share over the trailing 12 months (TTM)?
Guided Therapeutics EPS is -0.07 USD over the trailing 12 months.
Which sector does the Guided Therapeutics company belong to?
The Guided Therapeutics sector is Healthcare.